Transgene Biotek Ltd — Important, 01-09-2025: Company Update

Transgene Biotek faces insolvency proceedings initiated by M/s Babaji Nethralayya Private Limited over an unpaid secured loan. The company explains the repayment delay is a direct consequence of ongoing restrictions and penalties from SEBI and the Enforcement Directorate. Appeals against these orders at SAT and the Appellate Tribunal remain unresolved, hindering proper company function. Transgene Biotek aims to resolve this matter directly with M/s Babaji Nethralayya to prevent further progression of the insolvency process. This development highlights significant operational and financial challenges.